Morningside is part of Questel family of companies. We equip the world's leading life sciences organizations with a full suite of end-to-end language solutions for their regulatory, clinical, commercial and patent needs. In the clinical trial space Morningside provides translation and linguistic validation services to the world’s largest pharma companies, CROs and IRBs. We translate a wide range of clinical trial documents, from patient questionnaires to case report forms (CRFs). Our translators consistently deliver linguistically accurate, culturally adapted documents for the intended target audience. With over 4,000 clients in 55 countries, we’re globally recognized for our life science expertise and technology innovation across pharma, biotech, medical devices, and healthcare. Working exclusively with qualified subject matter experts (SME’s) is just part of our unwavering commitment to quality. Morningside employs ISO 9001, 13485, and 17001-compliant processes and controls, as well as a 3-tier linguistic review process. Our Information Security Management System (ISMS) is certified to ISO 27001:2013 which means our clients’ data is protected to the highest standard.
If you’ve ever lost sleep over delayed study enrollment, consider 1nHealth your new weighted blanket. 1nHealth fills studies through a simple philosophy: Don’t waste the power of…
Leveraging over 30 years of experience working with large biopharma, emerging biotech, CROs, and healthcare companies, the strategic advisors, executives, and subject matter…
Block Clinical is intently focused on streamlining the myriad of logistics involved in traditional, virtual, and hybrid clinical trials. From globally integrated patient…